Joined Today: 2

CVBT CardioVascular BioTherapeutics, Stock Message Board

All Messages

CVBT Message Board Home | Join The CVBT Group |

#26: CVBT's Pharmacoeconomics Strategy Recognized in Nature Biotechnology Magazine
The Machine	February 17, 2008 01:01:42 AM
CardioVascular BioTherapeutics, Inc. (OTCBB: CVBT) has been recognized in an article in the February 2008 issue of Nature Biotechnology Magazine for its progressive... view message ignore post recommend post

#25: Welcome to Las Vegas'' Sign Goes Red to Support AHA's Go Red for Women Campaign
The Machine	February 17, 2008 01:01:14 AM
CardioVascular BioTherapeutics, Inc. (OTCBB:CVBT): WHAT: ... view message ignore post recommend post

#24: SmallCap Sentinel: Coming to Doctor's Offices Everywhere
The Machine	February 17, 2008 01:00:51 AM
IRVINE, Calif., Jan. 14, 2008 (PRIME NEWSWIRE) -- "It seems ironic that a publication that is near-ubiquitous in doctor's offices everywhere... view message ignore post recommend post

#23: New Medical Treatment for Women's Heart Disease Discussed in Dr. Stegmann's Publication ''Holding a Woman's Heart in My Hands''
FastFun	October 24, 2007 06:39:23 PM
CardioVascular BioTherapeutics, Inc. (OTCBB: CVBT) has published a brochure authored by CVBT co-founder and cardiovascular surgeon Dr. Thomas Stegmann, titled “Holding a Woman’s Heart in... view message ignore post recommend post

#22: CardioVascular BioTherapeutics Completes Phase I Wound Healing Trial
FastFun	October 24, 2007 06:38:42 PM
CardioVascular BioTherapeutics, Inc. (OTCBB: CVBT) today announced the completion of its Phase I wound healing clinical trial aimed at evaluating the safety and tolerability of the... view message ignore post recommend post

#21: Pharmaceutical Executive Magazine Highlights CVBT's Angiogenesis Therapy for Its Promise as a Next-Generation Treatment for Heart Disease
FastFun	October 24, 2007 06:37:52 PM
CVBT Cited as ‘One of the Top Therapies and Technologies Vying to Deliver the Next Decade’s Break-Throughs and Blockbusters’ CardioVascular BioTherapeutics, Inc. (OTCBB:CVBT) today... view message ignore post recommend post

#20: CVBT News U.S. Patent Office Allows CVBT's Patent Application for the Injection of FGF-1 Into the Human Heart
NewsBot	January 9, 2007 06:00:00 AM
LAS VEGAS--(BUSINESS WIRE)--CardioVascular BioTherapeutics, Inc. (OTCBB:CVBT) today announced that the U.S. Patent and Trademark Office allowed CVBT’s patent application... view message ignore post recommend post

#19: CVBT News CardioVascular BioTherapeutics Seeks Listing on the AIM Market of the London Stock Exchange
NewsBot	October 26, 2006 07:21:00 AM
LAS VEGAS--(BUSINESS WIRE)--CardioVascular BioTherapeutics, Inc. (OTCBB:CVBT) has today announced that it is seeking to list its shares on the London Stock Exchange’s ... view message ignore post recommend post

#18: CVBT News CardioVascular BioTherapeutics Initiates Study on the Treatment of Peripheral Artery Disease
NewsBot	October 24, 2006 08:00:00 AM
LAS VEGAS--(BUSINESS WIRE)--CardioVascular BioTherapeutics, Inc. (OTCBB:CVBT) today announced that it is launching a new clinical trial to study the safety of a new drug candidate... view message ignore post recommend post

#17: CVBT News CardioVascular BioTherapeutics Appoints Mike Norris Vice President of Business Development
NewsBot	October 18, 2006 09:00:00 AM
LAS VEGAS--(BUSINESS WIRE)--CardioVascular BioTherapeutics, Inc. (OTCBB:CVBT), today announced it has named Mike Norris as Vice President of Corporate Development. In this position,... view message ignore post recommend post

#16: CVBT News CardioVascular BioTherapeutics Elects Dr. Thomas Stegmann Co-President
NewsBot	October 17, 2006 09:00:00 AM
LAS VEGAS--(BUSINESS WIRE)--CardioVascular BioTherapeutics, Inc. (OTCBB:CVBT), today announced that Thomas J. Stegmann, M.D., has been named co-president of the company. As co-founder... view message ignore post recommend post

#15: CVBT News Leading Osteoporosis Researcher to Explore Potential Use of Protein Therapy to Treat Osteoporosis
NewsBot	October 5, 2006 06:24:00 AM
LAS VEGAS--(BUSINESS WIRE)--CardioVascular BioTherapeutics, Inc. (OTCBB:CVBT), a biopharmaceutical company focused on the development of protein-based drugs for the treatment of... view message ignore post recommend post

#14: CVBT News CardioVascular BioTherapeutics Appoints Grant Gordon to Vice Chairman of Board
NewsBot	October 3, 2006 08:00:00 AM
LAS VEGAS--(BUSINESS WIRE)--CardioVascular BioTherapeutics, Inc. (OTCBB:CVBT), today announced that Grant Gordon has been named Vice Chairman of its Board of Directors. A... view message ignore post recommend post

#13: CVBT News Dutton Associates Announces Investment Opinion: CardioVascular BioTherapeutics Coverage Initiated By Dutton Associates
NewsBot	September 26, 2006 09:00:00 AM
EL DORADO HILLS, Calif.--(BUSINESS WIRE)--Dutton Associates initiates its coverage of CardioVascular BioTherapeutics (OTCBB:CVBT) with a Neutral rating. The 19-page report by Dutton... view message ignore post recommend post

#12: CVBT News CardioVascular BioTherapeutics to Present at 9Th Annual Financial Advisor Symposium in Chicago; Co-Founder to Discuss New Therapies for Cardiovascular Disease
NewsBot	September 20, 2006 06:00:00 AM
LAS VEGAS--(BUSINESS WIRE)--Sept. 20, 2006--CardioVascular BioTherapeutics, Inc. (OTCBB:CVBT) today announced that President and CEO Daniel C. Montano will discuss potential new therapies for the... view message ignore post recommend post

Group Home | Login if you want to post a message